Mary Elizabeth Ramsay
#102,870
Most Influential Person Now
Researcher
Mary Elizabeth Ramsay's AcademicInfluence.com Rankings
Mary Elizabeth Ramsayengineering Degrees
Engineering
#2726
World Rank
#3698
Historical Rank
Electrical Engineering
#532
World Rank
#587
Historical Rank
Mary Elizabeth Ramsaycomputer-science Degrees
Computer Science
#3691
World Rank
#3880
Historical Rank
Data Science
#32
World Rank
#32
Historical Rank
Computational Linguistics
#235
World Rank
#239
Historical Rank
Machine Learning
#511
World Rank
#517
Historical Rank
Download Badge
Engineering Computer Science
Mary Elizabeth Ramsay's Degrees
- PhD Computer Science Stanford University
- Masters Electrical Engineering University of California, Berkeley
- Bachelors Mathematics University of California, Berkeley
Similar Degrees You Can Earn
Why Is Mary Elizabeth Ramsay Influential?
(Suggest an Edit or Addition)Mary Elizabeth Ramsay's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant (2021) (1868)
- Global epidemiology of meningococcal disease. (2009) (773)
- Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study (2021) (758)
- Effectiveness of maternal pertussis vaccination in England: an observational study (2014) (613)
- Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction (2004) (599)
- Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study (2021) (488)
- Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story. (2001) (485)
- Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study (2020) (459)
- COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study (2021) (423)
- COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study (2021) (423)
- SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN) (2021) (415)
- Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis (2003) (411)
- Immunisation against infectious disease (2006) (394)
- Factors underlying parental decisions about combination childhood vaccinations including MMR: a systematic review. (2010) (368)
- Measles Outbreaks in a Population with Declining Vaccine Uptake (2003) (351)
- Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England (2001) (341)
- Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000-17: a prospective national observational cohort study. (2018) (332)
- A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales, 2012-2013. (2015) (326)
- Global epidemiology of invasive meningococcal disease (2013) (324)
- The changing and dynamic epidemiology of meningococcal disease. (2012) (308)
- Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines (2022) (307)
- Robust SARS-CoV-2-specific T-cell immunity is maintained at 6 months following primary infection (2020) (300)
- Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial (2021) (275)
- SARS-CoV-2 infection and transmission in educational settings: a prospective, cross-sectional analysis of infection clusters and outbreaks in England (2020) (250)
- Effectiveness of COVID-19 vaccines against the B.1.617.2 variant (2021) (228)
- Vaccine Effectiveness Estimates, 2004–2005 Mumps Outbreak, England (2007) (222)
- Epidemiology of meningococcal disease in England and Wales 1993/94 to 2003/04: contribution and experiences of the Meningococcal Reference Unit. (2006) (218)
- Hospital admissions attributable to rotavirus infection in England and Wales. (1996) (211)
- Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction (2016) (211)
- Invasive Haemophilus influenzae Disease, Europe, 1996–2006 (2010) (209)
- Increase in endemic Neisseria meningitidis capsular group W sequence type 11 complex associated with severe invasive disease in England and Wales. (2015) (189)
- Estimating Haemophilus influenzae type b vaccine effectiveness in England and Wales by use of the screening method. (2003) (185)
- Effectiveness of COVID-19 booster vaccines against COVID-19-related symptoms, hospitalization and death in England (2022) (182)
- Incidence and routes of transmission of hepatitis B virus in England and Wales, 1995-2000: implications for immunisation policy. (2004) (180)
- Early impact of the coronavirus disease (COVID-19) pandemic and physical distancing measures on routine childhood vaccinations in England, January to April 2020 (2020) (179)
- A surveillance network for meningococcal disease in Europe. (2007) (177)
- Viral Encephalitis in England, 1989–1998: What Did We Miss? (2003) (176)
- Prioritization of HCV treatment in the direct-acting antiviral era: An economic evaluation (2016) (167)
- Vaccination against meningococcal disease in Europe: review and recommendations for the use of conjugate vaccines. (2007) (161)
- Early effectiveness of COVID-19 vaccination with BNT162b2 mRNA vaccine and ChAdOx1 adenovirus vector vaccine on symptomatic disease, hospitalisations and mortality in older adults in England (2021) (160)
- Outcomes of invasive meningococcal serogroup B disease in children and adolescents (MOSAIC): a case-control study (2012) (157)
- Salivary diagnosis of measles: a study of notified cases in the United Kingdom, 1991-3 (1994) (149)
- Clinical and immunologic risk factors for meningococcal C conjugate vaccine failure in the United Kingdom. (2006) (145)
- Do antibody positive healthcare workers have lower SARS-CoV-2 infection rates than antibody negative healthcare workers? Large multi-centre prospective cohort study (the SIREN study), England: June to November 2020 (2021) (144)
- Effectiveness of BNT162b2 mRNA Vaccine Against Infection and COVID-19 Vaccine Coverage in Healthcare Workers in England, Multicentre Prospective Cohort Study (the SIREN Study) (2021) (139)
- COVID-19 in children: analysis of the first pandemic peak in England (2020) (137)
- Changing patterns of case ascertainment and trends in meningococcal disease in England and Wales. (1997) (137)
- Estimation of the risk of hepatitis B virus, hepatitis C virus and human immunodeficiency virus infectious donations entering the blood supply in England, 1993–2001 (2003) (137)
- Strengthening the Reporting of Molecular Epidemiology for Infectious Diseases (STROME-ID): an extension of the STROBE statement. (2014) (135)
- Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae. (2008) (134)
- Molecular Epidemiology of Human Group A Rotavirus Infections in the United Kingdom between 1995 and 1998 (2000) (133)
- U.K. parents' decision-making about measles-mumps-rubella (MMR) vaccine 10 years after the MMR-autism controversy: a qualitative analysis. (2012) (129)
- Interactions between SARS-CoV-2 and influenza, and the impact of coinfection on disease severity: a test-negative design (2020) (124)
- Invasive meningococcal disease in England and Wales: implications for the introduction of new vaccines. (2012) (122)
- The effectiveness of the mumps component of the MMR vaccine: a case control study. (2005) (122)
- Clinical course of hepatitis C virus during the first decade of infection: cohort study (2002) (113)
- Vaccination of Infants with Meningococcal Group B Vaccine (4CMenB) in England. (2020) (113)
- Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial (2021) (108)
- Prevalence of chronic viral hepatitis in people of south Asian ethnicity living in England: the prevalence cannot necessarily be predicted from the prevalence in the country of origin (2010) (106)
- HCV treatment rates and sustained viral response among people who inject drugs in seven UK sites: real world results and modelling of treatment impact (2014) (106)
- Changing patterns of invasive Haemophilus influenzae disease in England and Wales after introduction of the Hib vaccination programme (1996) (105)
- Meningococcal B Vaccine and Meningococcal Carriage in Adolescents in Australia. (2020) (102)
- Trends in bacterial, mycobacterial, and fungal meningitis in England and Wales 2004-11: an observational study. (2014) (101)
- W135 meningococcal disease in England and Wales associated with Hajj 2000 and 2001 (2002) (101)
- Mumps outbreaks across England and Wales in 2004: observational study (2005) (101)
- The epidemiology of measles in England and Wales: rationale for the 1994 national vaccination campaign. (1994) (100)
- Hepatitis C prevalence in England remains low and varies by ethnicity: an updated evidence synthesis. (2012) (99)
- Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection (2021) (98)
- Media dents confidence in MMR vaccine (1998) (97)
- The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccination. (2020) (97)
- Meningococcal serogroup C conjugate vaccination in England and Wales: coverage and initial impact of the campaign. (2002) (95)
- Resurgence of scarlet fever in England, 2014-16: a population-based surveillance study. (2017) (95)
- Effectiveness of Meningococcal B Vaccine against Endemic Hypervirulent Neisseria meningitidis W Strain, England (2016) (95)
- Rising incidence of Haemophilus influenzae type b disease in England and Wales indicates a need for a second catch-up vaccination campaign. (2003) (94)
- Enter B and W: two new meningococcal vaccine programmes launched (2015) (92)
- Omission bias and vaccine rejection by parents of healthy children: implications for the influenza A/H1N1 vaccination programme. (2010) (92)
- COVID-19 vaccine effectiveness against the omicron (BA.2) variant in England (2022) (91)
- Increased uptake and new therapies are needed to avert rising hepatitis C-related end stage liver disease in England: modelling the predicted impact of treatment under different scenarios. (2014) (87)
- An evidence synthesis approach to estimating Hepatitis C Prevalence in England and Wales (2009) (85)
- Parental confidence in measles, mumps and rubella vaccine: evidence from vaccine coverage and attitudinal surveys. (2002) (83)
- Rapid Declines in Age Group-Specific Rotavirus Infection and Acute Gastroenteritis Among Vaccinated and Unvaccinated Individuals Within 1 Year of Rotavirus Vaccine Introduction in England and Wales. (2016) (82)
- Tetanus in England and Wales, 1984-2000. (2003) (82)
- Presentation with gastrointestinal symptoms and high case fatality associated with group W meningococcal disease (MenW) in teenagers, England, July 2015 to January 2016. (2016) (81)
- Investigation of SARS-CoV-2 outbreaks in six care homes in London, April 2020 (2020) (80)
- The epidemiology of measles in England and Wales since the 1994 vaccination campaign. (1997) (80)
- Outcome of confirmed symptomatic congenital cytomegalovirus infection. (1991) (77)
- Trends in Haemophilus influenzae type b infections in adults in England and Wales: surveillance study (2004) (77)
- Emergency Meningococcal ACWY Vaccination Program for Teenagers to Control Group W Meningococcal Disease, England, 2015–2016 (2017) (75)
- The elimination of indigenous measles transmission in England and Wales. (2003) (75)
- Invasive Meningococcal Capsular Group Y Disease, England and Wales, 2007–2009 (2012) (75)
- Age-specific efficacy of pertussis vaccine during epidemic and non-epidemic periods (1993) (74)
- Effectiveness of 23-Valent Polysaccharide Pneumococcal Vaccine and Changes in Invasive Pneumococcal Disease Incidence from 2000 to 2017 in Those Aged 65 and Over in England and Wales (2018) (72)
- UK measles outbreak in non-immune anthroposophic communities: the implications for the elimination of measles from Europe (2000) (71)
- Invasive Haemophilus influenzae Serotype e and f Disease, England and Wales (2012) (69)
- High prevalence of SARS-CoV-2 antibodies in care homes affected by COVID-19: Prospective cohort study, England (2020) (69)
- Global practices of meningococcal vaccine use and impact on invasive disease (2014) (68)
- Temporal associations between national outbreaks of meningococcal serogroup W and C disease in the Netherlands and England: an observational cohort study. (2017) (68)
- Emergence of a Novel Coronavirus (COVID-19): Protocol for Extending Surveillance Used by the Royal College of General Practitioners Research and Surveillance Centre and Public Health England (2020) (68)
- The epidemiology of rubella in England and Wales before and after the 1994 measles and rubella vaccination campaign: fourth joint report from the PHLS and the National Congenital Rubella Surveillance Programme. (1997) (68)
- Increased risk of SARS-CoV-2 infection in staff working across different care homes: enhanced CoVID-19 outbreak investigations in London care Homes (2020) (68)
- A study of maternally derived measles antibody in infants born to naturally infected and vaccinated women (1996) (68)
- Mumps Complications and Effects of Mumps Vaccination, England and Wales, 2002–2006 (2011) (67)
- Stillbirths During the COVID-19 Pandemic in England, April-June 2020. (2020) (67)
- Fatal outcome from meningococcal disease--an association with meningococcal phenotype but not with reduced susceptibility to benzylpenicillin. (2002) (67)
- The epidemiology of acute meningitis in children in England and Wales (2003) (65)
- Evolution of surveillance of measles, mumps, and rubella in England and Wales: providing the platform for evidence-based vaccination policy. (2002) (65)
- Estimated progression rates in three United Kingdom hepatitis C cohorts differed according to method of recruitment. (2006) (64)
- The prevalence of hepatitis C in England and Wales. (2002) (64)
- Surveillance of measles in England and Wales: implications of a national saliva testing programme. (1997) (62)
- Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 (PIMS-TS): Prospective, national surveillance, United Kingdom and Ireland, 2020 (2021) (62)
- Hepatitis C Infection Among Injecting Drug Users in England and Wales (1992–2006): There and Back Again? (2009) (62)
- Risks of covid-19 hospital admission and death for people with learning disability: population based cohort study using the OpenSAFELY platform (2021) (60)
- SARS-CoV-2 infection and transmission in primary schools in England in June–December, 2020 (sKIDs): an active, prospective surveillance study (2021) (60)
- Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Invasive Pneumococcal Disease and Risk of Pneumococcal Coinfection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Prospective National Cohort Study, England (2020) (60)
- The diversity of measles virus in the United Kingdom, 1992-1995. (1997) (60)
- Pfizer-BioNTech and Oxford AstraZeneca COVID-19 vaccine effectiveness and immune response amongst individuals in clinical risk groups (2022) (59)
- Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England (2021) (59)
- Molecular epidemiology of a large outbreak of hepatitis B linked to autohaemotherapy (2000) (58)
- Invasive meningococcal disease among university undergraduates: association with universities providing relatively large amounts of catered hall accommodation (1999) (58)
- Mumps surveillance in England and Wales supports introduction of two dose vaccination schedule. (1997) (57)
- Meningococcal serogroup B strain coverage of the multicomponent 4CMenB vaccine with corresponding regional distribution and clinical characteristics in England, Wales, and Northern Ireland, 2007-08 and 2014-15: a qualitative and quantitative assessment. (2017) (57)
- Increase in scarlet fever notifications in the United Kingdom, 2013/2014. (2014) (56)
- Serological surveillance of SARS-CoV-2: Six-month trends and antibody response in a cohort of public health workers (2021) (56)
- Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial (2022) (55)
- Evaluation of the effect of the herpes zoster vaccination programme 3 years after its introduction in England: a population-based study (2017) (54)
- Effectiveness of COVID-19 vaccines against Omicron and Delta hospitalisation, a test negative case-control study (2022) (54)
- Causes of morbilliform rash in a highly immunised English population (2002) (53)
- SARS-CoV-2 infections in children following the full re-opening of schools and the impact of national lockdown: Prospective, national observational cohort surveillance, July-December 2020, England (2021) (53)
- An estimate of the proportion of diarrhoeal disease episodes seen by general practitioners attributable to rotavirus in children under 5 y of age in England and Wales (1999) (52)
- The introduction of the meningococcal B (MenB) vaccine (Bexsero®) into the national infant immunisation programme--New challenges for public health. (2015) (52)
- Impact of the COVID-19 Pandemic on Invasive Pneumococcal Disease and Risk of Pneumococcal Coinfection with SARS-CoV-2: prospective national cohort study, England (2020) (51)
- Prevalence of Serum Bactericidal Antibody to Serogroup C Neisseria meningitidis in England a Decade after Vaccine Introduction (2012) (50)
- SARS-CoV-2 infection and transmission in educational settings: cross-sectional analysis of clusters and outbreaks in England (2020) (50)
- New treatments for hepatitis C virus (HCV): scope for preventing liver disease and HCV transmission in England (2016) (50)
- Risk of invasive Haemophilus influenzae infection during pregnancy and association with adverse fetal outcomes. (2014) (50)
- Antibodies to SARS-CoV-2 protect against re-infection during outbreaks in care homes, September and October 2020 (2021) (49)
- Seroprevalence of low rubella IgG antibody levels among antenatal women in England tested by NHS Blood and Transplant: 2004-2009. Is rubella susceptibility increasing? (2012) (49)
- No evidence for capsule replacement following mass immunisation with meningococcal serogroup C conjugate vaccines in England and Wales. (2006) (48)
- Laboratory surveillance of hepatitis C virus infection in England and Wales: 1992 to 1996. (1998) (48)
- No evidence for Haemophilus influenzae serotype replacement in Europe after introduction of the Hib conjugate vaccine. (2008) (47)
- Outcome of pregnancy after maternal reinfection with rubella. (1991) (46)
- Changing attitudes to childhood immunisation in English parents. (2017) (45)
- Evaluating the population impact of hepatitis C direct acting antiviral treatment as prevention for people who inject drugs (EPIToPe) – a natural experiment (protocol) (2019) (45)
- Added value of PCR-testing for confirmation of invasive meningococcal disease in England. (2013) (45)
- Invasive Haemophilus influenzae type b disease in England and Wales: who is at risk after 2 decades of routine childhood vaccination? (2013) (44)
- Persistence of antibody after accelerated immunisation with diphtheria/tetanus/pertussis vaccine. (1991) (44)
- All-cause excess mortality observed by age group and regions in the first wave of the COVID-19 pandemic in England (2020) (43)
- Economic evaluation of infant and adolescent hepatitis B vaccination in the UK. (2011) (43)
- Disparities in the excess risk of mortality in the first wave of COVID-19: Cross sectional study of the English sentinel network (2020) (43)
- Control of hepatitis B in the United Kingdom. (1998) (43)
- Exposure of healthcare workers in England, Wales, and Northern Ireland to bloodborne viruses between July 1997 and June 2000: analysis of surveillance data (2001) (43)
- Attitudinal and demographic predictors of measles, mumps and rubella (MMR) vaccine acceptance: development and validation of an evidence-based measurement instrument. (2011) (43)
- Acute hepatitis B infection associated with blood transfusion in England and Wales, 1991-7: review of database (1999) (43)
- Antibody response and viral excretion after live polio vaccine or a combined schedule of live and inactivated polio vaccines. (1994) (42)
- First real world evidence of meningococcal group B vaccine, 4CMenB, protection against meningococcal group W disease; prospective enhanced national surveillance, England. (2020) (42)
- Adverse events and antibody response to accelerated immunisation in term and preterm infants. (1995) (42)
- Sentinel laboratory surveillance of hepatitis C antibody testing in England: understanding the epidemiology of HCV infection (2006) (42)
- Attitudinal and Demographic Predictors of Measles-Mumps-Rubella Vaccine (MMR) Uptake during the UK Catch-Up Campaign 2008–09: Cross-Sectional Survey (2011) (41)
- Effect of mass paediatric influenza vaccination on existing influenza vaccination programmes in England and Wales: a modelling and cost-effectiveness analysis (2017) (41)
- Continuing Impact of Infectious Diseases on Childhood Deaths in England and Wales, 2003–2005 (2010) (40)
- Risk of invasive meningococcal disease in children and adults with HIV in England: a population-based cohort study (2015) (39)
- Seven-fold increase in viral meningo-encephalitis reports in England and Wales during 2004-2013. (2014) (39)
- Haemophilus influenzae serotype b conjugate vaccine failure in twelve countries with established national childhood immunization programmes. (2010) (39)
- Acute hepatitis B infection in England and Wales: 1985–96 (1999) (39)
- Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial. (2022) (38)
- Hepatitis C in the UK: 2009 report. (2009) (38)
- A national survey of genitourinary medicine clinic attenders provides little evidence of sexual transmission of hepatitis C virus infection (2003) (37)
- Reinfection with new variants of SARS-CoV-2 after natural infection: a prospective observational cohort in 13 care homes in England (2021) (36)
- Should children be vaccinated against COVID-19 now? (2021) (36)
- Modeling Future Changes to the Meningococcal Serogroup C Conjugate (MCC) Vaccine Program in England and Wales (2006) (35)
- Protecting people with multiple sclerosis through vaccination (2020) (35)
- The rationale for the use of measles post-exposure prophylaxis in pregnant women: A review (2009) (35)
- THE CONTRIBUTION OF INFECTIONS TO NEONATAL DEATHS IN ENGLAND AND WALES (2011) (35)
- COVID-19 outbreaks following full reopening of primary and secondary schools in England: Cross-sectional national surveillance, November 2020 (2021) (35)
- Association between single-nucleotide polymorphisms in Mal/TIRAP and interleukin-10 genes and susceptibility to invasive haemophilus influenzae serotype b infection in immunized children. (2010) (34)
- Attitudes to immunisation in pregnancy among women in the UK targeted by such programmes (2015) (34)
- Effectiveness of the seven-valent and thirteen-valent pneumococcal conjugate vaccines in England: The indirect cohort design, 2006-2018. (2019) (34)
- Genotyping of acute HBV isolates from England, 1997-2001. (2009) (34)
- Shooting up: infections among injecting drug users in the United Kingdom 2006. An update: October 2007. (2007) (34)
- Effectiveness of BNT162b2 against COVID-19 in adolescents (2022) (34)
- Ascertainment of meningococcal disease in Europe. (2005) (34)
- Excess mortality in the first COVID pandemic peak: cross-sectional analyses of the impact of age, sex, ethnicity, household size, and long-term conditions in people of known SARS-CoV-2 status in England (2020) (34)
- Measles: the legacy of low vaccine coverage (2013) (34)
- Robust antibody responses in 70–80-year-olds 3 weeks after the first or second doses of Pfizer/BioNTech COVID-19 vaccine, United Kingdom, January to February 2021 (2021) (34)
- Monitoring the hepatitis C epidemic in England and evaluating intervention scale‐up using routinely collected data (2019) (33)
- Cost-effectiveness analysis of quadrivalent seasonal influenza vaccines in England (2017) (33)
- A unique measles B3 cluster in the United Kingdom and the Netherlands linked to air travel and transit at a large international airport, February to April 2014. (2016) (33)
- Survival of a national cohort of hepatitis C virus infected patients, 16 years after exposure (2005) (33)
- An outbreak caused by the SARS-CoV-2 Delta (B.1.617.2) variant in a care home after partial vaccination with a single dose of the COVID-19 vaccine Vaxzevria, London, England, April 2021 (2021) (33)
- Effect of Pneumococcal Conjugate Vaccines on Pneumococcal Meningitis, England and Wales, July 1, 2000–June 30, 2016 (2019) (32)
- Salivary diagnosis of rubella: a study of notified cases in the United Kingdom, 1991–4 (1998) (32)
- Meningococcal disease and sexual transmission: urogenital and anorectal infections and invasive disease due to Neisseria meningitidis (2020) (32)
- Real-world data shows increased reactogenicity in adults after heterologous compared to homologous prime-boost COVID-19 vaccination, March−June 2021, England (2021) (32)
- Guidance on the investigation and management of occupational exposure to hepatitis C. PHLS Advisory Committee on Blood Borne Viruses. (1999) (32)
- Understanding the impact of Hib conjugate vaccine on transmission, immunity and disease in the United Kingdom (2007) (31)
- Changes in the epidemiology of epiglottitis following introduction of Haemophilus influenzae type b (Hib) conjugate vaccines in England: a comparison of two data sources (2005) (31)
- Invasive meningococcal disease in patients with complement deficiencies: a case series (2008–2017) (2019) (30)
- Factors associated with incomplete vaccination of babies at risk of perinatal hepatitis B transmission: a London study in 2006. (2009) (30)
- Neonatal invasive Haemophilus influenzae disease in England and Wales: epidemiology, clinical characteristics, and outcome. (2015) (30)
- The prevalence and genetic diversity of hepatitis C infection in antenatal clinic attenders in two regions of England (2000) (29)
- Epidemiology, clinical presentation, risk factors, intensive care admission and outcomes of invasive meningococcal disease in England, 2010-2015. (2018) (29)
- Multitypic Hepatitis C Virus Infection Identified by Real-Time Nucleotide Sequencing of Minority Genotypes (2006) (29)
- Preparing for a challenging winter 2020/21 (2020) (28)
- The potential for measles transmission in England (2008) (28)
- Hepatitis C in ethnic minority populations in England (2008) (28)
- Frequent capsule switching in ‘ultra-virulent’ meningococci – Are we ready for a serogroup B ST-11 complex outbreak? (2017) (28)
- COVID-19 in Great Britain: epidemiological and clinical characteristics of the first few hundred (FF100) cases: a descriptive case series and case control analysis (2020) (28)
- Measuring childhood vaccine coverage in England: the role of Child Health Information Systems. (2012) (28)
- Recommendations for the prevention of secondary Haemophilus influenzae type b (Hib) disease. (2009) (28)
- Inequalities in childhood vaccination timing and completion in London. (2018) (27)
- Measles vaccine: a 27–year follow–up (1994) (27)
- Clinical and Molecular Epidemiology of Childhood Invasive Nontypeable Haemophilus influenzae Disease in England and Wales (2016) (27)
- Can current national surveillance systems in England and Wales monitor sexual transmission of hepatitis C among HIV-infected men who have sex with men? (2007) (27)
- Group B meningococcal vaccine: recommendations for UK use (2014) (27)
- Setting up an enhanced surveillance of newly acquired hepatitis C infection in men who have sex with men: a pilot in London and South East region of England. (2008) (26)
- Changing epidemiology of bacterial meningitis among adults in England and Wales 1991–2002 (2005) (26)
- Haemophilus influenzae type b vaccine—booster campaign (2003) (26)
- Long-term immunological follow-up of children with haemophilus influenzae serotype b vaccine failure in the United Kingdom. (2009) (26)
- Clusters of meningococcal disease in school and preschool settings in England and Wales: what is the risk? (2004) (26)
- Risk of SARS-CoV-2 reinfections in children: a prospective national surveillance study between January, 2020, and July, 2021, in England (2022) (26)
- Seroprevalence of SARS-CoV-2 antibodies in university students: Cross-sectional study, December 2020, England (2021) (25)
- The Effect of Measles on Health-Related Quality of Life: A Patient-Based Survey (2014) (25)
- Mapping the Gypsy Traveller community in England: what we know about their health service provision and childhood immunization uptake. (2013) (25)
- What have we learnt from measles outbreaks in 3 English cities? A qualitative exploration of factors influencing vaccination uptake in Romanian and Roma Romanian communities (2020) (25)
- B Part of It protocol: a cluster randomised controlled trial to assess the impact of 4CMenB vaccine on pharyngeal carriage of Neisseria meningitidis in adolescents (2018) (25)
- Meningococcal infection in pilgrims returning from the haj: update from Europe and beyond (2000) (24)
- Hepatitis B incidence among South Asian children in England and Wales: implications for immunisation policy (2003) (24)
- Five hepatitis B outbreaks in care homes in the UK associated with deficiencies in infection control practice in blood glucose monitoring (2010) (23)
- Molecular Epidemiology of Haemophilus influenzae Type b Causing Vaccine Failures in the United Kingdom (2006) (23)
- Establishing the cascade of care for hepatitis C in England—benchmarking to monitor impact of direct acting antivirals (2018) (23)
- Prevention of perinatal transmission of hepatitis B to babies at high risk: an evaluation. (2005) (23)
- Active surveillance of hepatitis C infection in the UK and Ireland (2000) (23)
- Host and environmental factors associated with Hib in England, 1998–2002 (2007) (22)
- Planning for the healthcare burden of hepatitis C infection: Hepatitis C genotypes identified in England, 2002-2007. (2010) (22)
- Reduction in rotavirus disease due to the infant immunisation programme in England; evidence from national surveillance. (2015) (22)
- Antibody responses and reactions to the whole cell pertussis component of a combined diphtheria/tetanus/pertussis vaccine given at school entry. (1995) (22)
- Serious pneumococcal disease outbreak in men exposed to metal fume - detection, response and future prevention through pneumococcal vaccination. (2017) (22)
- Infection and transmission of SARS-CoV-2 in London care homes reporting no cases or outbreaks of COVID-19: Prospective observational cohort study, England 2020 (2021) (22)
- The Expanded Programme on Immunization in the European Region of WHO Measles A strategic framework for the elimination of measles in the European Region (2000) (21)
- Parents' attitude towards the second dose of measles, mumps and rubella vaccine: a case-control study. (2003) (21)
- ‘I don’t think anybody explained to me how it works’: qualitative study exploring vaccination and primary health service access and uptake amongst Polish and Romanian communities in England (2019) (21)
- W135 meningococcal carriage in Hajj pilgrims (2002) (21)
- Acute and persistent symptoms in children with PCR-confirmed SARS-CoV-2 infection compared to test-negative children in England: active, prospective, national surveillance (2021) (21)
- HepSEQ: International Public Health Repository for Hepatitis B (2006) (21)
- Implications of Differential Age Distribution of Disease-Associated Meningococcal Lineages for Vaccine Development (2014) (21)
- Symptoms after accelerated immunisation. (1992) (21)
- Safety and Immunogenicity Report from the Com-COV Study – a Single-Blind Randomised Non-Inferiority Trial Comparing Heterologous And Homologous Prime-Boost Schedules with An Adenoviral Vectored and mRNA COVID-19 Vaccine (2021) (21)
- Hepatitis C virus: laboratory surveillance in England and Wales, 1992–2004 (2006) (21)
- Success of 4CMenB in preventing meningococcal disease: evidence from real-world experience (2020) (20)
- MMR immunisation after contact with measles virus (2004) (20)
- Emergence of SARS-CoV-2 Alpha (B.1.1.7) variant, infection rates, antibody seroconversion and seroprevalence rates in secondary school students and staff: Active prospective surveillance, December 2020 to March 2021, England (2021) (20)
- INVASIVE NEISSERIA MENINGITIDIS IN EUROPE 2003/2004 (2006) (20)
- PEPtalk: postexposure prophylaxis against varicella in children with cancer (2011) (20)
- Outbreak of measles among Irish Travellers in England, March to May 2007. (2007) (20)
- Evaluation of disease severity during SARS-COV-2 reinfection, January 2020 to April 2021, England: an observational study (2022) (20)
- Effectiveness of oral rotavirus vaccination in England against rotavirus-confirmed and all-cause acute gastroenteritis (2019) (20)
- Effectiveness of meningococcal vaccines at reducing invasive meningococcal disease and pharyngeal Neisseria meningitidis carriage: A systematic review and meta-analysis. (2020) (20)
- Oral Fluid Testing during 10 Years of Rubella Elimination, England and Wales (2010) (20)
- The Impact of Haemophilus influenzae Serotype B Resurgence on the Epidemiology of Childhood Invasive Haemophilus influenzae Disease in England and Wales (2011) (20)
- Protecting infants against measles in England and Wales: a review (2009) (19)
- The changing epidemiology of diphtheria in the United Kingdom, 2009 to 2017 (2020) (19)
- Immunisation of migrants in EU/EEA countries: Policies and practices. (2019) (19)
- Clinical diagnoses and outcomes of 4619 hospitalised cases of laboratory-confirmed invasive meningococcal disease in England: Linkage analysis of multiple national databases. (2016) (19)
- Haemophilus influenzae type b (Hib) seroprevalence and current epidemiology in England and Wales. (2017) (18)
- A National Sample of Individuals Who Acquired Hepatitis C Virus Infections in Childhood or Adolescence: Risk Factors for Advanced Disease (2007) (18)
- A measles outbreak in the Irish traveller ethnic group after attending a funeral in England, March–June 2007 (2009) (18)
- Changes in antibiotic resistance rates of invasive Haemophilus influenzae isolates in England and Wales over the last 20 years. (2008) (18)
- A European survey on public health policies for managing cases of meningococcal disease and their contacts. (2008) (17)
- Surveillance of hepatitis B: an example of a vaccine preventable disease. (1998) (17)
- Prevalence and incidence of hepatitis C in injecting drug users attending genitourinary medicine clinics (2008) (17)
- Functional T-Cell Deficiency in Adolescents Who Experience Serogroup C Meningococcal Disease despite Receiving the Meningococcal Serogroup C Conjugate Vaccine (2010) (17)
- Invasive meningococcal disease in England: assessing disease burden through linkage of multiple national data sources (2015) (17)
- Cost-effectiveness analysis of maternal immunisation against group B Streptococcus (GBS) disease: A modelling study. (2018) (17)
- Paediatric Multisystem Inflammatory Syndrome Temporally Associated with SARS-CoV-2 (PIMS-TS): Prospective, National Surveillance, UK and Ireland, 2020 (2021) (17)
- Rubella infection in pregnancy and congenital rubella in United Kingdom, 2003 to 2016 (2018) (16)
- Estimating hepatitis C infection acquired in England, 1986–2000 (2009) (16)
- Prioritising paediatric surveillance during the COVID-19 pandemic (2020) (16)
- “It’s a complex mesh”- how large-scale health system reorganisation affected the delivery of the immunisation programme in England: a qualitative study (2016) (15)
- OSH Manual of Childhood Infections: The Blue Book (2016) (15)
- Who is responsible for the vaccination of migrants in Europe? (2018) (15)
- Effect of priming interval on reactogenicity, peak immunological response, and waning after homologous and heterologous COVID-19 vaccine schedules: exploratory analyses of Com-COV, a randomised control trial (2022) (15)
- Detection of influenza A(H3N2) virus in children with suspected mumps during winter 2014/15 in England. (2015) (15)
- Estimating the burden of serogroup C meningococcal disease in England and Wales. (2002) (15)
- Keep calm and carry on vaccinating: Is anti-vaccination sentiment contributing to declining vaccine coverage in England? (2020) (15)
- Current epidemiology of tetanus in England, 2001–2014 (2016) (15)
- Summer music and arts festivals as hot spots for measles transmission: experience from England and Wales, June to October 2016 (2016) (15)
- Invasive Pneumococcal Disease in UK Children <1 Year of Age in the Post-13-Valent Pneumococcal Conjugate Vaccine Era: What Are the Risks Now? (2018) (15)
- Impact of Extending the Timing of Maternal Pertussis Vaccination on Hospitalized Infant Pertussis in England, 2014–2018 (2020) (14)
- The contribution of transfusion to HCV infection in England (2002) (14)
- PEPtalk2: results of a pilot randomised controlled trial to compare VZIG and aciclovir as postexposure prophylaxis (PEP) against chickenpox in children with cancer (2018) (14)
- Disease severity during SARS-COV-2 reinfection: a nationwide study (2022) (14)
- MMR uptake data are unlikely to be subject to manipulation (2002) (14)
- Evaluation of the measles, mumps and rubella vaccination catch-up campaign in England in 2013. (2014) (14)
- Seroprevalence of SARS-CoV-2 among Blood Donors and Changes after Introduction of Public Health and Social Measures, London, UK (2021) (14)
- UK prevalence of underlying conditions which increase the risk of severe COVID-19 disease: a point prevalence study using electronic health records (2020) (14)
- What school-level and area-level factors influenced HPV and MenACWY vaccine coverage in England in 2016/2017? An ecological study (2019) (13)
- SARS-CoV-2 infection in London, England: changes to community point prevalence around lockdown time, March–May 2020 (2020) (13)
- Hepatitis A outbreak among men who have sex with men (MSM) in England, 2016–2018: The contribution of past and current vaccination policy and practice☆ (2019) (13)
- Real-world data on immune responses following heterologous prime-boost COVID-19 vaccination schedule with Pfizer and AstraZeneca vaccines in England (2021) (13)
- Invasive Meningococcal Disease, 2011–2020, and Impact of the COVID-19 Pandemic, England (2021) (13)
- An outbreak of hepatitis A affecting a nursery school and a primary school (2010) (13)
- The epidemiology of meningococcal disease in England and Wales, 1996 and 1997. (1997) (13)
- Risk factors, clinical features and genotype distribution of diagnosed hepatitis C virus infections: a pilot for a sentinel laboratory-based surveillance. (2003) (13)
- Implementation and evaluation of the human papillomavirus (HPV) vaccination pilot for men who have sex with men (MSM), England, April 2016 to March 2017 (2019) (13)
- SARS Antibody Testing in Children: Development of Oral Fluid Assays for IgG Measurements (2022) (13)
- Rising incidence of Haemophilus influenzae type b disease in England and Wales indicates the need for a second catch-up campaign (2003) (13)
- Surveillance for Viral Hepatitis (2008) (13)
- Using surveillance data to determine treatment rates and outcomes for patients with chronic hepatitis C virus infection (2014) (13)
- Universal hepatitis B vaccination. (2008) (13)
- SARS-CoV-2 infection, antibody positivity and seroconversion rates in staff and students following full reopening of secondary schools in England: A prospective cohort study, September–December 2020 (2021) (13)
- Hepatitis B transmission event in an English prison and the importance of immunization. (2011) (13)
- Impact of COVID-19 vaccination program on seroprevalence in blood donors in England, 2021 (2021) (13)
- Monitoring HIV testing in diverse healthcare settings: results from a sentinel surveillance pilot study (2010) (12)
- Risk of invasive meningococcal disease in university students in England and optimal strategies for protection using MenACWY vaccine. (2017) (12)
- The importance of tetanus risk assessment during wound management (2014) (12)
- Mortality rates among individuals diagnosed with hepatitis C virus (HCV); an observational cohort study, England, 2008 to 2016 (2019) (12)
- Long-term complications and risk of other serious infections following invasive Haemophilus influenzae serotype b disease in vaccinated children. (2010) (12)
- Assessing optimal use of the standard dose adjuvanted trivalent seasonal influenza vaccine in the elderly. (2019) (12)
- Immunoglobulin deficiency in children with Hib vaccine failure. (2011) (12)
- The public health implications of secondary measles vaccine failure. (2013) (12)
- Maximising benefit, reducing inequalities and ensuring deliverability: Prioritisation of COVID-19 vaccination in the UK (2020) (12)
- Infant hospitalisations and fatalities averted by the maternal pertussis vaccination programme in England, 2012-2017: Post-implementation economic evaluation. (2020) (12)
- Polio eradication: surveillance implications for the United Kingdom. (1997) (12)
- COVER/Körner 95-1 (April to June 1995). Vaccination coverage statistics for children up to 2 years old in the United Kingdom. (1995) (12)
- Enhanced surveillance scheme for suspected meningococcal disease in five regional health authorities in England: 1998. (2002) (12)
- Editorial Commentary: The Story of Sisyphus: Why We Need a Universal Pneumococcal Vaccine to Replace Current Conjugate Vaccines. (2015) (12)
- Prospective Active National Surveillance of Preschools and Primary Schools for SARS-CoV-2 Infection and Transmission in England, June 2020: (sKIDs: COVID-19 Surveillance in School KIDs) (2021) (11)
- Epidemiology and Clinical Features of Childhood Chronic Hepatitis B Infection Diagnosed in England (2014) (11)
- Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021–March, 2022: a national, observational, test-negative, case-control study (2022) (11)
- Molecular epidemiology of newly acquired hepatitis C infections in England 2008-2011: genotype, phylogeny and mutation analysis. (2015) (11)
- Vaccine-derived rotavirus strains in infants in England (2019) (11)
- Sustained detection of type 2 poliovirus in London sewage between February and July, 2022, by enhanced environmental surveillance (2022) (11)
- Detection of the United States Neisseria meningitidis urethritis clade in the United Kingdom, August and December 2019 – emergence of multiple antibiotic resistance calls for vigilance (2020) (11)
- Surge in SARS-CoV-2 transmission in school-aged children and household contacts, England, August to October 2021 (2021) (11)
- Characteristics associated with COVID-19 vaccine uptake among adults aged 50 years and above in England (8 December 2020–17 May 2021): a population-level observational study (2022) (11)
- Epidemiological and clinical characteristics of early COVID-19 cases, United Kingdom of Great Britain and Northern Ireland (2020) (11)
- Major milestone reached in global polio eradication. (2000) (11)
- Acute infectious hepatitis in hospitalised children: a British Paediatric Surveillance Unit study (2017) (10)
- Effectiveness of ChAdOx1-S COVID-19 booster vaccination against the Omicron and Delta variants in England (2022) (10)
- Risk of invasive bacterial infections by week of age in infants: prospective national surveillance, England, 2010–2017 (2019) (10)
- Cross sectional investigation of a COVID-19 outbreak at a London Army barracks: Neutralising antibodies and virus isolation (2020) (10)
- Meningococcal C booster not recommended by evidence (2008) (10)
- Using automated extraction of hepatitis B tests for surveillance: evidence of decreasing incidence of acute hepatitis B in England (2011) (10)
- Shooting Up: infections in injecting drug users in the United Kingdom, 2002 (2004) (10)
- The prevalence of hepatitis B infection in adults with no recognized increased risk of infection. (2000) (10)
- Prevalence of HIV in England and Wales in 1996: Annual Report of the Unlinked Anonymous Prevalence Monitoring Programme (1997) (10)
- Hepatitis C testing in sexual health services in England, 2002–7: results from sentinel surveillance (2009) (10)
- Preventing secondary cases of invasive meningococcal capsular group B (MenB) disease using a recently-licensed, multi-component, protein-based vaccine (Bexsero(®)). (2014) (10)
- Invasive meningococcal disease: timing and cause of death in England, 2008-2015. (2020) (10)
- Meningococcal Group W Disease in Infants and Potential Prevention by Vaccination (2016) (10)
- National Outbreak of Pertussis in England, 2011-2012: A Case-control Study Comparing 3-Component and 5-Component Acellular Vaccines With Whole-cell Pertussis Vaccines. (2020) (10)
- Short-term changes in the health state of children with group B meningococcal disease: A prospective, national cohort study (2017) (10)
- Children develop strong and sustained cross-reactive immune responses against spike protein following SARS-CoV-2 infection (2021) (10)
- SIREN protocol: Impact of detectable anti-SARS-CoV-2 on the subsequent incidence of COVID-19 in 100,000 healthcare workers: do antibody positive healthcare workers have less reinfection than antibody negative healthcare workers? (2020) (10)
- The contribution of single antigen measles, mumps and rubella vaccines to immunity to these infections in England and Wales (2007) (10)
- Regular mass screening for SARS-CoV-2 infection in care homes already affected by COVID-19 outbreaks: Implications of false positive test results (2020) (9)
- Outbreaks of serious pneumococcal disease in closed settings in the conjugate vaccines era, 2010-2018: a systematic review to inform national guidance in the UK. (2019) (9)
- Increased Incidence of Invasive Pneumococcal Disease among Children after COVID-19 Pandemic, England (2022) (9)
- Saliva antibody testing and vaccination in a mumps outbreak. (1991) (9)
- Workshop on vaccine pressure and Neisseria meningitidis, Annecy, France, 9-11 March 2005. (2007) (9)
- Revised recommendations for the prevention of secondary Haemophilus influenzae type b (Hib) disease. (2013) (9)
- Emergence of a Novel Coronavirus (COVID-19): Protocol for Extending Surveillance Used by the Royal College of General Practitioners Research and Surveillance Centre and Public Health England (Preprint) (2020) (8)
- Chronic hepatitis B virus case-finding in UK populations born abroad in intermediate or high endemicity countries: an economic evaluation (2019) (8)
- Influenza and Respiratory Virus Surveillance, Vaccine Uptake, and Effectiveness at a Time of Cocirculating COVID-19: Protocol for the English Primary Care Sentinel System for 2020-2021 (2020) (8)
- Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality (1995) (8)
- Variable clinical presentation by the main capsular groups causing invasive meningococcal disease in England. (2019) (8)
- Seasonal influenza surveillance and vaccine effectiveness at a time of co-circulating COVID-19: Oxford-Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC) and Public Health England (PHE) protocol for winter 2020/21 (Preprint) (2020) (8)
- OpenSAFELY: Risks of COVID-19 hospital admission and death for people with learning disabilities - a cohort study. (2021) (8)
- Triangulation of measles vaccination data in the United Kingdom of Great Britain and Northern Ireland (2019) (8)
- Measles on a cruise ship: links with the outbreak in the Philippines. (2014) (8)
- Compliance with follow-up after occupational exposure to hepatitis C. (2007) (8)
- The impact of mode of acquisition on biological markers of paediatric hepatitis C virus infection (2011) (8)
- Assessing the impact of a nurse-delivered home dried blood spot service on uptake of testing for household contacts of hepatitis B-infected pregnant women across two London trusts (2016) (7)
- Primary meningococcal conjunctivitis: summary of evidence for the clinical and public health management of cases and close contacts. (2019) (7)
- Extracting general practice data for timely vaccine coverage estimates: The England experience. (2017) (7)
- Strengthening HPV vaccination delivery: findings from a qualitative service evaluation of the adolescent girls’ HPV vaccination programme in England (2019) (7)
- Diagnoses of, and deaths from, severe liver disease due to hepatitis C in England between 2000 and 2005 estimated using multiple data sources (2008) (7)
- COVID-19 vaccine given to children with comorbidities in England, December 2020–June 2021 (2021) (7)
- Timely immunisation of premature infants against rotavirus in the neonatal intensive care unit (2014) (7)
- Improving uptake of immunisation. Mobile children miss out. (1993) (7)
- Epidemiology of group a rotaviruses surveillance and burden of disease studies. (2000) (7)
- Secondary attack rate and family clustering of SARS-CoV-2 infection in children of healthcare workers with confirmed COVID-19 (2020) (7)
- Serological responses to COVID-19 Comirnaty booster vaccine, London, United Kingdom, September to December 2021 (2022) (7)
- Outbreak strain characterisation and pharyngeal carriage detection following a protracted group B meningococcal outbreak in adolescents in South-West England (2019) (7)
- Neisseria meningitidis W135: 2a: P1.2,5 arising from successive pilgrimages to Mecca (2001) (7)
- Haemophilus influenzae type b epiglottitis. Article gives timely lesson. (2003) (7)
- Meningococcal infection in pilgrims returning from the Haj. (2000) (6)
- Hepatitis B Virus Immunization and Neonatal Acquisition of Persistent Infection in England and Wales (2018) (6)
- Introduction and epidemiology of meningococcal disease (2016) (6)
- COVID-19 Outbreaks Following Full Reopening of Primary and Secondary Schools in England: Retrospective, Cross-Sectional National Surveillance (2021) (6)
- Risk of thrombosis with thrombocytopenia syndrome after COVID‐19 vaccination prior to the recognition of vaccine‐induced thrombocytopenia and thrombosis: A self‐controlled case series study in England (2022) (6)
- Causes of death among persons diagnosed with hepatitis C infection in the pre‐ and post‐DAA era in England: A record linkage study (2019) (6)
- An Increase in Group B Invasive Meningococcal Disease Among Adolescents and Young Adults in England Following Easing of COVID-19 Containment Measures (2021) (6)
- Killing 2 Cocci With 1 Vaccine: Unleashing the Full Potential of an Adolescent Meningococcal B Immunization Program. (2020) (6)
- Infection‐related mortality in children with malignancy in England and Wales, 2003–2005 (2009) (6)
- B Part of It School Leaver protocol: an observational repeat cross-sectional study to assess the impact of a meningococcal serogroup B (4CMenB) vaccine programme on carriage of Neisseria meningitidis (2019) (6)
- Severe Acute Respiratory Syndrome Coronavirus 2 Infections in Primary School Age Children After Partial Reopening of Schools in England (2021) (6)
- Characterising long COVID more than 6 months after acute infection in adults; prospective longitudinal cohort study, England (2021) (6)
- Author Correction: Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection (2021) (6)
- Summary of evidence to reduce the two-dose infant priming schedule to a single dose of the 13-valent pneumococcal conjugate vaccine in the national immunisation programme in the UK. (2020) (5)
- Adverse events after school leavers received combined tetanus and low dose diphtheria vaccine. (1997) (5)
- MMR vaccine coverage in the UK falls after adverse publicity (1998) (5)
- Investigating the aetiology of and evaluating the impact of the Men C vaccination programme on probable meningococcal disease in England and Wales (2006) (5)
- Pertussis immunisation in children with a family or personal history of convulsions: a review of children referred for specialist advice. (1994) (5)
- Hepatitis B virus transmission in pre-adolescent schoolchildren in four multi-ethnic areas of England (2012) (5)
- Long-term health-related quality of life in non-hospitalised COVID-19 cases with confirmed SARS-CoV-2 infection in England: Longitudinal analysis and cross-sectional comparison with controls (2021) (5)
- Exploring the effects of BCG vaccination in patients diagnosed with tuberculosis: Observational study using the Enhanced Tuberculosis Surveillance system. (2019) (5)
- Low serum serotype-specific pneumococcal antibody concentrations in young children with Haemophilus influenzae serotype b (Hib) vaccine failure. (2010) (5)
- Serological surveillance of SARS-CoV-2: trends and humoral response in a cohort of public health workers (2020) (5)
- Invasive meningocccal disease among university undergraduates association with catered halls of residence (1999) (5)
- Effectiveness of the COVID-19 vaccines against hospitalisation with Omicron sub-lineages BA.4 and BA.5 in England (2022) (5)
- HIV coinfection among persons diagnosed with hepatitis B in England in 2008–2014 (2019) (5)
- Emergence of the delta variant and risk of SARS-CoV-2 infection in secondary school students and staff: Prospective surveillance in 18 schools, England (2021) (5)
- Antibody persistence and neutralising activity in primary school students and staff: Prospective active surveillance, June to December 2020, England (2021) (5)
- Varicella postexposure prophylaxis in children with cancer: urgent need for a randomised controlled trial (2012) (4)
- SARS-CoV-2 infection in London, England: Impact of lockdown on community point-prevalence, March-May 2020 (2020) (4)
- INVASIVE HAEMOPHILUS INFLUENZAE IN EUROPE - 2001 (2003) (4)
- Impact of prior SARS-CoV-2 infection and COVID-19 vaccination on the subsequent incidence of COVID-19: a multicentre prospective cohort study among UK healthcare workers – the SIREN (Sarscov2 Immunity & REinfection EvaluatioN) study protocol (2022) (4)
- Impact of the herpes zoster vaccination programme on hospitalised and general practice consulted herpes zoster in the 5 years after its introduction in England: a population-based study (2020) (4)
- Accelerated immunisation with diphtheria-tetanus-pertussis vaccine. (1991) (4)
- No conspiracy regarding recommendation for a group B meningococcus vaccine (2014) (4)
- Should the UK introduce a universal childhood varicella vaccination programme? (2015) (4)
- Monitoring the COVID-19 immunisation programme through a national immunisation Management system – England’s experience (2021) (4)
- Two centuries of immunisation in the UK (part II) (2019) (4)
- Signs and symptoms of liver disease after 10 years of infection with hepatitis C virus. Data from a national cohort of patients who acquired their infections on a known date (2000) (4)
- Robust Antibody Responses in 70-80 Year Olds following 1 or 2 Doses of Pfizer COVID-19 Vaccine (2021) (4)
- COVER (COVER of vaccination evaluated rapidly): 31. (1994) (4)
- Ethnic differences in the incidence of clinically diagnosed influenza: an England population-based cohort study 2008-2018. (2021) (4)
- What is the cost of delivering routine vaccinations at GP practices in England? A comparative time-driven activity-based costing analysis (2019) (4)
- Exploring the effects of BCG vaccination in patients diagnosed with tuberculosis: observational study using the Enhanced Tuberculosis Surveillance system (2018) (3)
- Question 1: Does prophylactic paracetamol prevent fever after vaccination in infants? (2015) (3)
- Impact of a nurse‐led enhanced monitoring, management and contact tracing intervention for chronic hepatitis B in England, 2015‐2017 (2020) (3)
- HepSEQ--an integrated hepatitis B epidemiology and sequence analysis platform. (2008) (3)
- The impact of social and physical distancing measures on COVID-19 activity in England: findings from a multi-tiered surveillance system (2021) (3)
- Community seroprevalence of SARS-CoV-2 in children and adolescents in England, 2019–2021 (2022) (3)
- A Re-emergence of Subacute Sclerosing Panencephalitis in the United Kingdom (2022) (3)
- Perceptions of adolescents on the COVID-19 pandemic and returning to school: qualitative questionnaire survey, September 2020, England (2022) (3)
- Secondary attack rates in primary and secondary school bubbles following a confirmed case: Active, prospective national surveillance, November to December 2020, England (2021) (3)
- Rapid reporting system for meningitis W135: 2a:P1.2, 5 prompted by haj (2000) (3)
- Accuracy of perceptions of hepatitis B and C status (2000) (3)
- uenza vaccination programmes in England and Wales: a modelling and cost-eff ectiveness analysis (2018) (3)
- Association of Age, Gender, Deprivation, Urbanicity, Ethnicity, and Smoking with a Positive Test for COVID-19 in an English Primary Care Surveillance Network: Cross Sectional Study of the First 500 Cases (2020) (3)
- Evaluating the impact of a continued maternal pertussis immunisation programme in England: A modelling study and cost-effectiveness analysis. (2021) (3)
- Vaccine Effectiveness Against Infection and Death Due to SARS-CoV-2, Following One and Two Doses of the BNT162b2 and ChADox-1 in Residents of Long-Term Care Facilities in England, Using a Time-Varying Proportional Hazards Model (2021) (3)
- Hepatitis C virus genotype 4 in England: Diversity and demographic associations (2015) (3)
- Surveillance optimisation to detect poliovirus in the pre-eradication era: a modelling study of England and Wales (2020) (3)
- Invasive meningococcal disease as a cause of sudden and unexpected death in a teenager: The public health importance of confirming the diagnosis. (2018) (3)
- Rapid reporting EU surveillance system for meningitis W135: 2a: P1.2, 5 – update (2001) (3)
- School-based vaccination programmes: An evaluation of school immunisation delivery models in England in 2015/16. (2020) (3)
- Impact of an accelerated measles-mumps-rubella (MMR) vaccine schedule on vaccine coverage: An ecological study among London children, 2012–2018 (2021) (3)
- Mapping the hepatitis C cascade of care in people attending drug treatment services in England: A data linkage study. (2019) (3)
- Increase in mumps cases in England and Wales, 2004 (2004) (3)
- Epidemiology of SARS-CoV-2 infection among staff and students in a cohort of English primary and secondary schools during 2020–2021 (2022) (3)
- When Should Vaccination Be Contraindicated in Children? (2005) (3)
- Feasibility and acceptability of SARS-CoV-2 testing and surveillance in primary school children in England: Prospective, cross-sectional study (2021) (2)
- Ethnic differences in the incidence of clinically diagnosed influenza: an England population-based cohort study 2008-2018 (2021) (2)
- Improved hepatitis C treatment response in younger patients: findings from the UK HCV National Register cohort study (2011) (2)
- Comparisons of hepatitis B and C and HIV prevalence rates. (2000) (2)
- Rapid reporting system for meningitis W135: 2a: P1.2, 5: update (2001) (2)
- World Health Organization aims to eliminate measles in Europe by 2007 (1997) (2)
- Measles data are reliable (1995) (2)
- Optimizing Benefits of Testing Key Workers for Infection with SARS-CoV-2: A Mathematical Modeling Analysis (2020) (2)
- Characteristics associated with COVID-19 vaccine uptake among adults in England (08 December to 17 May 2021) (2021) (2)
- Two centuries of immunisation in the UK (part 1) (2019) (2)
- Sustained declines in age group-specific rotavirus infection and acute gastroenteritis in vaccinated and unvaccinated individuals during the five years since Rotavirus vaccine introduction in England. (2021) (2)
- Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection (2021) (2)
- The importance of a preschool booster for children born to hepatitis B-positive mothers (2013) (2)
- at risk after two decades of routine childhood vaccination (2013) (2)
- Imported cases of polio in Bulgaria – vaccination campaign postponed (2001) (2)
- Very low risk of monkeypox among staff and students after exposure to a confirmed case in educational settings, England, May to July 2022 (2022) (2)
- Representativeness, Vaccination Uptake, and COVID-19 Clinical Outcomes 2020-2021 in the UK Oxford-Royal College of General Practitioners Research and Surveillance Network: Cohort Profile Summary (2022) (2)
- Monitoring liver transplant rates in persons diagnosed with hepatitis C: a data linkage study, England 2008 to 2017 (2019) (2)
- Effectiveness of BNT162b2 and ChAdOx-1 vaccines in residents of long-term care facilities in England using a time-varying proportional hazards model (2022) (2)
- Retrospective cohort study of liver transplantation in the United Kingdom between 1994 and 2010: the impact of hepatitis C infection. (2015) (2)
- Smart Scheduling - optimising national immunisation programmes to achieve maximum impact. (2019) (2)
- The effect of measles on health-related quality of life: a population-based prospective study (2013) (1)
- COVER (cover of vaccination evaluated rapidly): 32. (1995) (1)
- Re: Manikkavasagan G, Ramsay M. 2009. The rationale for the use of measles post-exposure prophylaxis in pregnant women: a review. Journal of Obstetrics and Gynaecology 29(7):574–577 (2010) (1)
- Where is anti-HCV testing taking place in England? (2006) (1)
- COVID-19 Outbreaks in Nurseries During Rapid Spread of the B.1.1.7 Variant of SARS-CoV-2 in England: Cross-Sectional National Surveillance, November 2020 – January 2021 (2021) (1)
- Timing of meningococcal vaccination with 4CMenB (Bexsero®) in children with invasive meningococcal group B (MenB) disease in England. (2022) (1)
- Effectiveness of BNT162b2 COVID-19 booster vaccine against covid-19 related symptoms and hospitalization in England (2022) (1)
- Meningococcal infection in pilgrims returning from the 2001 Muslim pilgrimage in Mecca (the haj) (2001) (1)
- Ethnic differences in the incidence of clinically diagnosed influenza: an England population-based cohort study 2008-2018. (2021) (1)
- COVID-19 and SARS-CoV-2 Seropositivity in Children of Healthcare Workers in London (2020) (1)
- Risk of Paediatric Multisystem Inflammatory Syndrome (PIMS-TS) During the SARS-CoV-2 Alpha and Delta Variant Waves: National Observational Study, 2020-21, England (2022) (1)
- Estimating true hospital morbidity of complications associated with mumps outbreak, England, 2004/05 (2016) (1)
- Unvaccinated child dies of Haemophilus influenzae type b infection. (1999) (1)
- The epidemiology of invasive non-type b encapsulated Haemophilus influenzae disease in England & Wales in the era of routine Hib immunisation (2011) (1)
- Viral meningitis in Cyprus and England : summer 1996. (1996) (1)
- Trends in deaths from malignant neoplasia of liver are poor indicator of hepatitis C infection (1999) (1)
- Comparing Individual and Population Prevention Benefits of Early Direct-Acting Antiviral Treatment for HCV (2016) (1)
- How to Prevent Vaccines Falling Victim to Their Own Success: Intertemporal Dependency of Incidence Levels on Indirect Effects in Economic Reevaluations (2021) (1)
- Effectiveness of one dose of MVA-BN smallpox vaccine against mpox in England using the case-coverage method: an observational study. (2023) (1)
- Is partnership the answer? Delivering the national immunisation programme in the new English health system: a mixed methods study (2019) (1)
- Update on the MMR vaccine controversy in the UK (2001) (1)
- Rotavirus: a new vaccine for the UK? (1999) (1)
- Health Inequalities and Infectious Diseases (2013) (1)
- Increased Incidence of Invasive Pneumococcal Disease in Children in England: July to December 2021, Compared to Pre-Pandemic Years (2017-2019) (2022) (1)
- COVID-19 deaths in children and young people in England, March 2020 to December 2021: An active prospective national surveillance study (2022) (1)
- Surveillance for viral hepatitis in Europe (2013) (1)
- 'B Part of It' School Leaver study: a repeat cross-sectional study to assess the impact of increasing coverage with meningococcal B (4CMenB) vaccine on carriage of Neisseria meningitidis. (2021) (1)
- Perceptions of Adolescents on the COVID-19 Pandemic and Returning to School: Qualitative Questionnaire Survey, England 2020 (2021) (1)
- Seropositivity and risk factors for SARS-CoV-2 infection in staff working in care homes during the COVID-19 pandemic (2020) (1)
- Immunological imprinting of humoral immunity to SARS-CoV-2 in children (2023) (1)
- Public health leadership in the UK's response to hepatitis A and hepatitis B vaccine shortages. (2020) (1)
- New Treatments for HCV: Scope for Preventing Liver Disease and HCV Transmission in England (2016) (1)
- COVID-19 Deaths in Children and Young People: Active Prospective National Surveillance, March 2020 to December 2021, England (2022) (1)
- UK prevalence of risk factors for severe COVID-19 disease, by age and region: point prevalence estimates in 2019 and 2014, using electronic health records (2020) (0)
- Understanding immunisation failure of neonatal HBV prevention (2015) (0)
- Meningoencephalitis after measles-mumps-rubella vaccine. (1991) (0)
- Measles vaccine: a27-year follow-up (1994) (0)
- (2019). Data linkage to monitor hepatitis C-associated end-stage liver disease and hepatocellular carcinoma inpatient stays in England. Journal of Viral Hepatitis. (2019) (0)
- University of Dundee Evaluating the population impact of hepatitis C direct acting antiviral treatment as prevention for people who inject drugs ( EPIToPe ) (2019) (0)
- Invasive Haemophilus infl uenzae Serotype e and f Disease , England and Wales (2019) (0)
- HEPSEQ: a web-accessible, quality-based, molecular, clinical and epidemiological web resource for hepatitis B infection (2006) (0)
- Vaccinationagainstmeningococcal disease inEurope : reviewand recommendations for theuseof conjugatevaccines (2006) (0)
- Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England (2021) (0)
- The UK HCV national register A national resource to inform the natural history of hepatitis C infection (1999) (0)
- Antibody Persistence After Primary SARS-CoV-2 Infection and Protection Against Future Variants Including Omicron in Adolescents: National, Prospective Cohort Study. (2023) (0)
- Meningococcal disease associated with the 2001 haj – update (2001) (0)
- OP-IJEJ210080 1124..1133 (2021) (0)
- Excess Mortality and Its Association with SARS-CoV-2 Status During the First Pandemic Peak: Cross-Sectional Analyses of the English Primary Care Surveillance Network (2020) (0)
- Post-Licensure Impact of Haemophilus influenzae Type b and Serogroup C Neisseria meningitidis Conjugate Vaccines in Industrialized Countries (2009) (0)
- mRNA COVID-19 vaccines induce enhanced antibody and cellular responses compared to ChAdOx1 or natural infection in children (2021) (0)
- A cross-sectional national investigation of COVID-19 outbreaks in nurseries during rapid spread of the Alpha (B.1.1.7) variant of SARS-CoV-2 in England (2022) (0)
- Haemophilus influenzae type b epiglottitis [9] (multiple letters) (2003) (0)
- Vaccination for the Control of Meningococcal Disease: the Use of Meningococcal Vaccines from the Public Health Perspective (2006) (0)
- There is no need for further research on the ineffective Spf66 malaria vaccine (1997) (0)
- Annotations Rotavirus : a new vaccine for the UK ? (0)
- Lineages for Vaccine Development of Disease-Associated Meningococcal Implications of Differential Age Distribution (2014) (0)
- SARS-CoV-2 Infections in Children Following the Re-Opening of Schools and the Impact of National Lockdown during Autumn 2020: Prospective, National Observational Cohort Surveillance, England (2021) (0)
- Immunogenicity and Reactogenicity of BNT162b2 and mRNA1273 COVID-19 Vaccines Given as Fourth Dose Boosters in the COV-BOOST Randomised Trial Following Two Doses of ChAdOx1 nCov-19 or BNT162b2 and a Third Dose of BNT162b2 (2022) (0)
- Immunisation of migrants in EWEEA countries: Policies and practices (2019) (0)
- Author Correction: Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England (2022) (0)
- Rapid reporting EU surveillance system for meningitis W135: 2a: P1.2, 5 – update and summary (2001) (0)
- Title: SARS-CoV-2 infection in London, England: Impact of lockdown on community point- (2020) (0)
- Modelling the Impact of COVID-19 on Meningococcal Carriage and Disease in the UK (2021) (0)
- Significantly lower infection fatality rates associated with SARS-CoV-2 Omicron (B.1.1.529) infection in children and young people: Active, prospective national surveillance, January-March 2022, England (2023) (0)
- The Impact of the COVID-19 Pandemic on Invasive Pneumococcal Disease and the Risk of Pneumococcal Coinfection with SARS-CoV-2: Prospective National Cohort Surveillance, England (2020) (0)
- Meningococcal infection in England and Wales: 1999–2001 (2002) (0)
- Hepatitis B and C in ethnic minority populations in England (2006) (0)
- Meningococcal infection and the haj: surveillance and prevention (2001) (0)
- Real World Data Demonstrating Increased Reactogenicity in Adults Receiving Heterologous Compared to Homologous Prime-Boost COVID-19 Vaccination: March-May 2021, England (2021) (0)
- The Impact of Social and Physical Distancing Measures on COVID-19 Activity in England (2020) (0)
- Hib in England, 19982002 Host and environmental factors associated with (2009) (0)
- Data linkage to monitor hepatitis C‐associated end‐stage liver disease and hepatocellular carcinoma inpatient stays in England (2019) (0)
- Early impact of the COVID-19 pandemic and social distancing measures on routine childhood vaccinations in England, January to April 2020 (2020) (0)
- The clinical course of hepatitis C virus infection in those who acquired their infections in childhood (2005) (0)
- Immunization (2020) (0)
- mRNA or ChAd0x1 COVID-19 Vaccination of Adolescents Induces Robust Antibody and Cellular Responses With Continued Recognition of Omicron Following mRNA-1273 (2022) (0)
- Acute hepatitis B in injecting drug users is increasing in England and Wales as initiative to improve vaccine coverage begins (1999) (0)
- Chapter 1 Introduction and epidemiology of meningococcal disease (0)
- Research/Recherche Surveillance ofmeasles inEngland andWales: implications ofanational saliva testing programme (1997) (0)
- Reducing ambulance conveyance for older people with and without dementia: evidence of the role of social care from a regional, year-long service evaluation using retrospective routine data (2021) (0)
- Commentary on ‘Combined DTP‐HBV‐HIB vaccine versus separately administered DTP‐HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB)’ (2011) (0)
- Vaccination catch-up campaign in response to recent increase in invasive Hib infection in the United Kingdom – implications for the rest of Europe? (2003) (0)
- The contribution o f transfusion to HCV infection in England THE ENGLISH NATIONAL BLOOD SERVICE HCV LOOKBACK COLLATION COLLABORATORS (2012) (0)
- P27: Estimating transmission rates of hepatitis B (HBV) in households of HBV infected pregnant women in London (2013) (0)
- Optimising protection from measles in infants (2018) (0)
- Ascertainment of meningococcal disease in Europe. (2005) (0)
- Hepatitis B Virus Diagnosis and monitoring : P 24 – P 27 Natural history and epidemiology : P 28 – P 31 HBV : DIAGNOSIS (2013) (0)
- Measles: Achieving National Control of a Vaccine Preventable Infection (2018) (0)
- Impact of conjugate group C meningococcal vaccination in the United Kingdom (2001) (0)
- The Ethics of Overruling Parental Refusal of Neonatal Hepatitis B Vaccination for Babies Born to Mothers with Hepatitis B Virus Infection (2020) (0)
- Feasibility and Acceptability of SARS-CoV-2 Testing and Surveillance in Primary School Children in England (2021) (0)
- WITHDRAWN: Evaluation of Childhood Haemophilus Influenzae Serotype B (HIB) Vaccine Failure in Europe (2006) (0)
- Time to review policy on contraindictions to vaccination (2000) (0)
- Effectiveness of COVID-19 booster vaccines against COVID-19-related symptoms, hospitalization and death in England (2022) (0)
- COVER (cover of vaccination evaluated rapidly): 33. (1995) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Mary Elizabeth Ramsay?
Mary Elizabeth Ramsay is affiliated with the following schools:
